Press release
Artificial Intelligence in Drug Discovery Market is expected to grow at a CAGR of 42.5% during the forecasted period | Evolve Business Intelligence
Key Highlights:• The global Artificial Intelligence in Drug Discovery Market size was valued at USD 1.2 billion in 2023 growing at a CAGR of 42.5% from 2023 to 2033.
• North America dominated the market in 2023
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033
As per the study initiated by Evolve Business Intelligence, the global Artificial Intelligence in Drug Discovery Market size accounted for USD 1.2 Billion in 2023, growing at a CAGR of 42.5% from 2023 to 2033. Artificial Intelligence (AI) has significantly impacted the field of drug discovery, revolutionizing the way researchers identify potential drug candidates and optimize the drug development process.
Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021286
AI algorithms can analyze biological data to identify potential drug targets by understanding the complex relationships within biological systems. This helps researchers focus their efforts on targets with higher therapeutic potential. AI enables the rapid screening of vast chemical libraries to identify potential drug candidates. Machine learning models can predict the biological activity of compounds, helping researchers design molecules with desired properties. AI algorithms can predict the pharmacokinetics and toxicity of potential drug candidates, allowing researchers to optimize compounds earlier in the drug development process and reduce the likelihood of failures in later stages. AI facilitates the analysis of large-scale patient data, including genomic and clinical information, to identify patient subgroups and tailor treatments based on individual characteristics. This move towards personalized medicine aims to improve treatment efficacy and reduce adverse effects.
Key Players
Some of the major Artificial Intelligence in Drug Discovery Market players holding high market shares include IBM Watson; Exscientia; GNS Healthcare; Alphabet (DeepMind); and Benevolent AI. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include BioSymetrics; Euretos; Berg Health; Atomwise; Insitro; Cyclica
Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021286
Segmental Analysis
Based on therapeutic area, Artificial Intelligence in the Drug Discovery market is segmented into Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, and Others. Oncology is the largest therapeutic area in the AI in Drug Discovery market. This is due to the high unmet need for effective cancer treatments and the potential of AI to accelerate the development of new therapies. AI is being used to identify new drug targets, predict the efficacy and safety of drug candidates, and design personalized cancer treatments.
Based on application, Artificial Intelligence in the Drug Discovery market is Drug Optimization and Repurposing, Preclinical Testing, and Others. Drug optimization and repurposing is the largest application segment in the AI in the Drug Discovery market. This is due to the potential of AI to improve the success rate of drug development by identifying new uses for existing drugs and optimizing the properties of existing drug candidates. AI is being used to predict the off-target effects of drugs, identify new drug targets, and design new drug formulations.
Based on components, Artificial Intelligence in the Drug Discovery market is a Software, Hardware, and Services. Software is the largest component segment of the AI in the Drug Discovery market. This is because AI software is the most versatile and adaptable tool for drug discovery. AI software can be used to perform a wide range of tasks, from identifying new drug targets to predicting the efficacy and safety of drug candidates.
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)
Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence in Drug Discovery Market is expected to grow at a CAGR of 42.5% during the forecasted period | Evolve Business Intelligence here
News-ID: 3293000 • Views: …
More Releases from Evolve Business Intelligence
![Lingerie Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Opportunities and Trends](https://cdn.open-pr.com/L/9/L906452765_g.jpg)
Lingerie Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, O …
The Lingerie Market is witnessing robust growth, with a market size of US$ 88.32 billion in 2023 and a projected compound annual growth rate (CAGR) of 6.14% from 2023 to 2033. The market is driven by an increasing emphasis on body positivity and inclusivity, which has led to a broader range of sizes, styles, and designs that cater to diverse body types and personal preferences. Brands are now focusing on…
![Karaoke Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Opportunities and Trends](https://cdn.open-pr.com/L/9/L906516033_g.jpg)
Karaoke Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Op …
The Karaoke Market is experiencing steady growth, with a market size of US$ 1.02 billion in 2023 and a projected compound annual growth rate (CAGR) of 3.65% from 2023 to 2033. The market is driven by significant technological advancements and the widespread digitalization of entertainment platforms. Innovations such as high-quality sound systems, user-friendly karaoke apps, and online karaoke platforms have made karaoke more accessible and appealing to a broader audience.…
![Feed Yeast Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Opportunities and Trends](https://cdn.open-pr.com/L/9/L906951795_g.jpg)
Feed Yeast Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, …
The Feed Yeast Market is positioned for substantial growth, with an estimated market size of US$ 1.41 billion in 2023 and a projected compound annual growth rate (CAGR) of 4.83% from 2023 to 2033. The market is primarily driven by the rising demand for sustainable and natural feed additives. As consumers and industries alike become more conscious of sustainability and natural product ingredients, feed yeast offers an attractive alternative to…
![Carbonated Soft Drinks Market Analysis and Forecast to 2033: COVID-19 and Post-COVID Impact, Opportunities and Trends](https://cdn.open-pr.com/L/9/L906199864_g.jpg)
Carbonated Soft Drinks Market Analysis and Forecast to 2033: COVID-19 and Post-C …
The Carbonated Soft Drinks Market is a substantial segment within the global beverage industry, projected to reach a market size of US$ 247.32 billion in 2023. The market is anticipated to grow at a compound annual growth rate (CAGR) of 4.97% from 2023 to 2033. The wide consumer appeal and global consumption of carbonated soft drinks are significant driving factors for this market. These beverages are popular across various age…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…